416 related articles for article (PubMed ID: 22397783)
1. Retroperitoneal lymph node dissection with concomitant IVC thrombectomy, caval wall resection, and grafting for metastatic NSGCT.
Hakky T; Kim T; Rodriguez AR; Armstrong P; Mangar D; Spiess PE
Int Braz J Urol; 2012; 38(1):135; discussion 136. PubMed ID: 22397783
[TBL] [Abstract][Full Text] [Related]
2. Robot-assisted laparoscopic retroperitoneal lymph node dissection with concomitant inferior vena cava thrombectomy for metastatic mixed testicular germ cell cancer: a case report.
Zhang K; Zhu G; Liu X; Tian J; Gu Y; Zhai M; Yang L; Liu W; Li H; Martinez Portillo FJ
J Med Case Rep; 2019 Aug; 13(1):272. PubMed ID: 31451109
[TBL] [Abstract][Full Text] [Related]
3. Long-term results after inferior vena caval resection during retroperitoneal lymphadenectomy for metastatic germ cell cancer.
Beck SD; Lalka SG
J Vasc Surg; 1998 Nov; 28(5):808-14. PubMed ID: 9808847
[TBL] [Abstract][Full Text] [Related]
4. Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection.
Johnston P; Beck SD; Cheng L; Masterson TA; Bihrle R; Kesler K; Foster RS
J Urol; 2013 Sep; 190(3):874-7. PubMed ID: 23517745
[TBL] [Abstract][Full Text] [Related]
5. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
[TBL] [Abstract][Full Text] [Related]
6. [Caval involvement in advanced-stage non-seminoma testicular tumors: surgical strategy and long-term results].
Tavolini IM; Norcen M; Oliva G; Nigro F; Benedetto G; Mazzariol C; Bassi P
Arch Ital Urol Androl; 2002 Jun; 74(2):69-76. PubMed ID: 12161940
[TBL] [Abstract][Full Text] [Related]
7. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
[TBL] [Abstract][Full Text] [Related]
8. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
9. Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part I--Vena cava.
Donohue JP; Thornhill JA; Foster RS; Bihrle R
World J Urol; 1994; 12(4):182-6. PubMed ID: 7820138
[TBL] [Abstract][Full Text] [Related]
10. Resection of the inferior vena cava or intraluminal vena caval tumor thrombectomy during retroperitoneal lymph node dissection for metastatic germ cell cancer: indications and results.
Donohue JP; Thornhill JA; Foster RS; Rowland RG; Bihrle R
J Urol; 1991 Aug; 146(2):346-9. PubMed ID: 1649925
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
[TBL] [Abstract][Full Text] [Related]
12. Robot - assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor.
Torricelli FC; Jardim D; Guglielmetti GB; Patel V; Coelho RF
Int Braz J Urol; 2017; 43(1):171. PubMed ID: 28124545
[TBL] [Abstract][Full Text] [Related]
13. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
[TBL] [Abstract][Full Text] [Related]
14. Successful emergency endovascular aortic repair for intratumoral hemorrhage in extensive retroperitoneal mass of testicular origin.
Hulova S; Aziri R; Vulev I; Palacka P; Kolnikova G; Rejlekova K; Chovanec M; Mardiak J; Pindak D; Mego M
BMC Surg; 2020 Nov; 20(1):272. PubMed ID: 33160340
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
16. Retroperitoneal vascular surgery for the treatment of giant growing teratoma syndrome.
Stella M; Gandini A; Meeus P; Aleksic I; Flechon A; Cropet C; Droz JP; Rivoire M
Urology; 2012 Feb; 79(2):365-70. PubMed ID: 22173179
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.
Nakamura T; Oishi M; Ueda T; Fujihara A; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Urol; 2015 Jul; 22(7):663-8. PubMed ID: 25847721
[TBL] [Abstract][Full Text] [Related]
18. Complete Vascular Replacement of the Infrarenal Inferior Vena Cava and Abdominal Aorta during Post-Chemotherapy Retroperitoneal Lymph Node Dissection for a Non-Seminomatous Germ Cell Tumor.
Evmorfopoulos K; Chasiotis G; Barbatis A; Zachos I; Kouvelos G; Bareka M; Vlachostergios PJ; Arnaoutoglou E; Tzortzis V; Matsagkas M
Curr Oncol; 2023 Jun; 30(6):5448-5455. PubMed ID: 37366895
[TBL] [Abstract][Full Text] [Related]
19. Primary vs. post-chemotherapy retroperitoneal lymph node dissection (RPLND) in patients with presence of teratoma at orchiectomy.
Williams SB; Kacker R; Steele GS; Richie JP
Urol Oncol; 2012; 30(1):60-3. PubMed ID: 20189842
[TBL] [Abstract][Full Text] [Related]
20. Resection of the inferior vena cava without reconstruction for urologic malignancies.
Duty B; Daneshmand S
Urology; 2009 Dec; 74(6):1257-62. PubMed ID: 19819533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
